• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Bio-Rad

Bio-Rad names Roop Lakkaraju as CFO

March 20, 2024 By Danielle Kirsh

Bio-Rad today announced it appointed Roop K. Lakkaraju as EVP and chief financial officer, effective April 15. Lakkaraju joins the clinical diagnostics and imaging systems company from Benchmark Electronics where he served as EVP and chief financial officer and was responsible for all finance-related functions since 2018. “We are pleased to welcome Roop Lakkaraju as […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Bio-Rad, Personnel Moves

Bio-Rad announces $500M share repurchase program

July 21, 2023 By Sean Whooley

Bio-Rad Laboratories announced that its board of directors approved a new share repurchase program. The program grants the company authority to repurchase up to $500 million in outstanding shares of its common stock. “The new share buyback authorization is consistent with our disciplined approach and demonstrates our continued commitment to using this tool as part […]

Filed Under: Business/Financial News, Diagnostics, Funding Roundup, Genomics/Molecular Diagnostics, Wall Street Beat Tagged With: Bio-Rad, Bio-Rad Laboratories

Bio-Rad stock dips as COVID-19-related sales taper off in Q3

October 28, 2022 By Sean Whooley

Bio-Rad (NYSE:BIO) shares took a hit on third-quarter results that came in mixed compared to the consensus forecast. BIO shares were down more than 6% at $359.75 apiece this morning — a day after the company released its results. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Bio-Rad, coronavirus, COVID-19

Bio-Rad acquires Curiosity Diagnostics for up to $170M

August 4, 2022 By Sean Whooley

Bio-Rad Laboratories (NYSE:BIO) announced that it agreed to acquire all outstanding shares of Curiosity Diagnostics. Hercules, California-based Bio-Rad bought Curiosity Diagnostics from Scope Fluidics, a Warsaw, Poland-based developer of technologies for the medical diagnostic and healthcare markets, for a total consideration of up to $170 million. The acquisition consists of approximately $100 million in cash, […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Bio-Rad, Bio-Rad Laboratories

These 10 medtech companies’ stocks performed best in 2021

March 7, 2022 By Sean Whooley

Following a year like no other in 2020, 2021 was when many looked to rebound — including the medtech industry. A number of medtech companies followed up a challenging, pandemic-enveloped year with impressive performances. Plenty of them had already proven in 2020 that they were capable of a quick bounce-back. Here are 10 medtech companies […]

Filed Under: Business/Financial News, Cardiovascular, Diabetes, Featured, News Well, Orthopedics, Wall Street Beat Tagged With: Abbott, Abiomed, atricure, Bio-Rad, Dexcom, Edwards Lifesciences, ICU Medical, Inspire Medical Systems Inc., ResMed, Stryker

Bio-Rad beats The Street in Q4, despite nearly $1.6B loss

February 11, 2022 By Danielle Kirsh

Bio-Rad posted fourth-quarter results that beat the overall consensus on Wall Street. The Hercules, California–based clinical diagnostics company yesterday evening reported losses of $1.573 billion, or $52.59 per share, on sales of $732.8 million for the three months ended Dec. 31, 2021. In comparison, the company earned $839.1 million, or $27.81 pers share off sales […]

Filed Under: Business/Financial News, Diagnostics, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Bio-Rad, Sartorius

Bio-Rad appoints Simon May as life sciences group president

December 16, 2021 By Danielle Kirsh

Bio-Rad today announced that it appointed Simon May as executive VP and life sciences group president, effective January 4, 2022. May succeeds Annette Tumolo who is retiring. He will be responsible for providing leadership and management of the overall strategy and business direction for the company’s life science group global operations. “We are pleased to […]

Filed Under: Business/Financial News Tagged With: Bio-Rad

How medtech fared in the first waves of the pandemic

November 18, 2021 By Danielle Kirsh

Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial […]

Filed Under: Business/Financial News, Featured Tagged With: Ambu, Bio-Rad, biomerieux, Cardiovascular Systems, Centers for Medicare and Medicaid Services, danaher, Dexcom, Dräger, Fisher & Paykel Healthcare, Getinge, Insulet, Invacare, Konica Minolta, Masimo, Medtronic, Montagu Private Equity, Nevro Corp., NovoCure, Olympus, ResMed, RTI Surgical, Surgalign

Abbott alleges former employee took COVID-19-related trade secrets

November 3, 2020 By Brian Buntz

Abbott (NYSE:ABT) has obtained a temporary restraining order against a former marketing executive. The company alleges the former employee stole trade secrets, including details of upcoming COVID-19 products, before accepting a role at a competitor. Virginia Kendall, a U.S. District Judge for the Northern District of Illinois, decided to grant the two-week restraining order against Jerome […]

Filed Under: Diagnostics, Featured, Legal News Tagged With: Abbott Laboratories, Bio-Rad, Bio-Rad Laboratories, coronavirus, COVID-19

AdvaMed unveils COVID-19 diagnostic supply registry

July 21, 2020 By Sean Whooley

AdvaMed announced today that it created a comprehensive national COVID-19 diagnostic supply registry to aid state and federal pandemic responses. According to a news release, AdvaMed is launching the registry in partnership with 13 commercial diagnostics manufacturers: Abbott (NYSE:ABT), Becton Dickinson (NYSE:BDX), bioMérieux, Bio-Rad Laboratories (NYSE:BIO), Beckman Coulter, Cepheid, Hologic (NSDQ:HOLX), Ortho Clinical Diagnostics, Qiagen (NYSE:QGEN), Roche Diagnostics, Sekisui Diagnostics, […]

Filed Under: Business/Financial News, Diagnostics, Featured Tagged With: Abbott, AdvaMed, Beckman Coulter Inc., becton dickinson, Bio-Rad, BioMerieux Inc., Cepheid, coronavirus, COVID-19, Hologic, Ortho Clinical Diagnostics, Qiagen N.V., Roche Diagnostics, Sekisui Chemical Co. Ltd., Siemens Healthineers, Thermo Fisher Scientific

Bio-Rad acquires Celsee

April 10, 2020 By Danielle Kirsh

Bio-Rad Laboratories (NYSE:BIO) this week said it acquired Celsee for an undisclosed amount. Celsee develops instruments and consumables for the isolation, detection and analysis of single cells. The company’s Genesis System allows scientists to isolate, analyze and interpret cellular behavior and collect cell-based information for improved results in single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment […]

Filed Under: Mergers & Acquisitions Tagged With: Bio-Rad

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy